Quick answer: The rate of childhood chronic illness has increased dramatically over the past 40 years — with ADHD, autism spectrum disorder, food allergies, childhood obesity, pediatric autoimmune conditions, and anxiety/depression all rising substantially. Functional pediatrics investigates the environmental, nutritional, microbiome, and genetic factors driving this epidemic of childhood chronic illness and provides evidence-based approaches that pediatric offices operating on 15-minute visits cannot offer.
The Pediatric Chronic Illness Epidemic: Causes and Scope
By multiple measures, today’s children are less healthy than their parents’ generation despite dramatic advances in acute care medicine:
ADHD prevalence: 11% of US children (CDC 2022), up from 3-5% in the 1980s. Autism spectrum disorder: 1 in 36 children (CDC 2023 ADDM Network), compared to 1 in 150 in 2000. Food allergy: 8% of US children (FARE 2020), with peanut allergy prevalence tripling since 1997. Childhood obesity: 19.7% of US children ages 2-19 (CDC 2020), compared to 5% in the early 1970s. Pediatric type 2 diabetes: increasing 4.8% annually (TODAY2 study). Pediatric autoimmune conditions (type 1 diabetes, juvenile idiopathic arthritis, inflammatory bowel disease): all rising. Childhood anxiety and depression: 9.4% of children 3-17 have anxiety, 4.4% have depression (Ghandour 2019 Pediatrics), with significant COVID-era acceleration.
This is not primarily a genetic epidemic — the genome doesn’t change this rapidly. It is an environmental, epigenetic, and microbiome-mediated epidemic, driven by factors that functional pediatrics directly addresses.
The Infant Microbiome: Founding the Foundation
The gut microbiome is established in the first 1,000 days of life — from conception through age 2 — and this early colonization pattern has lifelong health consequences. Understanding the critical windows and disruptions enables targeted intervention:
Mode of delivery: Vaginal birth exposes the infant to the maternal vaginal and fecal microbiome — including Lactobacillus, Bacteroides, and Bifidobacterium infantis — initiating a microbial colonization cascade. Cesarean section delivery bypasses this exposure, resulting in an initial colonization primarily from skin and hospital environmental bacteria. Dominguez-Bello 2010 (PNAS) demonstrated that C-section infants have a distinct, less diverse microbiome compared to vaginal birth infants. C-section delivery is associated with increased lifetime risk of asthma, allergies, obesity, type 1 diabetes, and celiac disease — effects mediated through altered early microbiome colonization. “Vaginal seeding” (swabbing C-section newborns with maternal vaginal secretions) is being studied as a microbiome restoration approach; preliminary data is promising but protocols are still being optimized.
Breastfeeding: Human breast milk is far more than nutrition — it contains: human milk oligosaccharides (HMOs, over 200 distinct molecules) that selectively feed Bifidobacterium infantis; secretory IgA (mucosal immune education); lactoferrin (antimicrobial, anti-inflammatory); and living maternal immune cells. Victora 2016 Lancet global breastfeeding meta-analysis: breastfed children have 13% lower risk of obesity, 19% lower risk of type 2 diabetes, 58% lower sudden infant death risk, and higher cognitive scores. Bifidobacterium infantis, flourishing on HMOs, is a critical early colonizer that produces indole-3-lactic acid (suppressing inflammation) and short-chain fatty acids (supporting barrier function) — and it is dramatically reduced in formula-fed infants.
Antibiotic exposure in early life: Each course of antibiotics in the first 2 years of life significantly disrupts microbiome development. Hviid 2006 (American Journal of Epidemiology, n=12,000 Danish children) found early antibiotic use associated with 40% increased overweight risk. Metsälä 2013 (Pediatric Allergy and Immunology) demonstrated early antibiotic exposure increased asthma risk by 31-39%. Cox 2014 (Cell) showed early-life antibiotic disruption of microbiome in mice permanently altered metabolic programming — including fat storage — effects lasting into adulthood despite microbiome apparent recovery. The functional medicine approach: (1) Reserve antibiotics for clear bacterial infections (not viral URI, otitis media with effusion, most pharyngitis). (2) When antibiotics are necessary, prescribe Saccharomyces boulardii concurrently (anti-diarrheal, C. diff protective, reduces antibiotic-associated microbiome damage). (3) Post-antibiotic microbiome restoration with Lactobacillus rhamnosus GG, Bifidobacterium strains, and prebiotic fiber.
ADHD: Functional Medicine Root Cause Evaluation
ADHD — affecting 11% of US school-age children — is treated almost exclusively with stimulant medications in conventional pediatrics, yet functional medicine identifies multiple modifiable contributors that are rarely assessed:
Iron deficiency: Iron is required for dopamine synthesis (dopamine β-hydroxylase is iron-dependent) and for the dopamine transporter (DAT) — the molecular target of stimulant ADHD medications. Konofal 2008 Pediatrics demonstrated ADHD children have lower serum ferritin (16 ng/mL) than controls (28 ng/mL). Importantly, ferritin below 30 ng/mL (not the conventional “anemia” threshold) is associated with ADHD severity. Iron supplementation alone in iron-deficient ADHD children improves behavior scores significantly (Konofal 2008, Sever 1997). Ferritin should be assessed in every ADHD evaluation — this is a direct, correctable cause.
Omega-3 deficiency: The omega-3 to omega-6 ratio is critical for dopaminergic and noradrenergic neurotransmission — membrane EPA/DHA content affects receptor density and signal transduction. The Bélanger 2009 meta-analysis (Journal of Pediatric Psychology) found omega-3 supplementation significantly improved ADHD symptoms. Milte 2012 (Prostaglandins, Leukotrienes and Essential Fatty Acids RCT): omega-3 supplementation improved reading, spelling, and behavioral ADHD symptoms. The omega-3 index (HS-Omega-3 Index) should be a standard component of functional ADHD evaluation. Target: >8% omega-3 index; intervention: 1-2g EPA+DHA/day.
Magnesium deficiency: Starobrat-Hermelin 1997 (Magnesium Research) found 95% of ADHD children were magnesium deficient. Magnesium modulates NMDA receptor activity — relevant to prefrontal cortex executive function. Magnesium glycinate or malate (3-6mg/kg/day) is commonly used in functional pediatrics for ADHD, often combined with vitamin B6 (P5P form — required for GABA and serotonin synthesis). The Mousain-Bosc 2006 Magnesium Research RCT demonstrated significant ADHD symptom reduction with magnesium-B6 combination.
Food dyes and additives: The McCann 2007 Lancet DOUBLE-BLIND RCT (n=297 children) demonstrated that artificial food colors (AFC — tartrazine, sunset yellow, carmoisine, ponceau 4R) combined with sodium benzoate significantly increased hyperactivity in both ADHD-diagnosed and healthy children. This led the UK FSA to recommend removing these dyes; the EU requires a “may have an adverse effect on activity and attention” label. The FDA has not acted comparably. Elimination of artificial food colors is a first-line intervention in functional pediatrics for ADHD and behavioral concerns.
Zinc deficiency: Zinc is required for dopamine synthesis and is a cofactor for fatty acid desaturation enzymes. Arnold 2005 (Journal of Child & Adolescent Psychopharmacology) found adjunctive zinc supplementation significantly improved ADHD symptoms in zinc-deficient children. Zinc levels correlate inversely with ADHD symptom severity in multiple studies.
Sleep disorders: Undiagnosed sleep-disordered breathing (obstructive sleep apnea, upper airway resistance syndrome) produces significant neurocognitive impairment — inattention, hyperactivity, and behavioral dysregulation — that is frequently misidentified as ADHD. The Chervin 2006 (Sleep) demonstrated that adenotonsillectomy for pediatric sleep-disordered breathing significantly reduced ADHD-like behaviors in multiple follow-up studies. Sleep evaluation with polysomnography referral when clinically indicated should precede ADHD medication initiation.
Autism Spectrum Disorder: The Functional Medicine Framework
Autism spectrum disorder (ASD) involves a complex interaction of genetic susceptibility and environmental factors — both of which are increasingly understood through the functional medicine lens. The rapidly rising prevalence (1 in 36, a 317% increase since 2000) demands investigation of modifiable factors:
Gut-brain axis in autism: ASD children have higher rates of GI symptoms (constipation, diarrhea, abdominal pain) than neurotypical controls — affecting 30-70% in various studies. Adams 2011 and Kang 2019 have documented specific microbiome differences in ASD vs controls: reduced Prevotella, reduced Bifidobacterium, elevated Clostridium species. Kang 2017 (Microbiome) and Kang 2019 (Scientific Reports) conducted fecal microbiota transplant in ASD children — documenting significant improvement in GI symptoms AND ASD behavioral scores, with improvements persisting 2 years after FMT. The gut-brain axis connection in autism may operate through multiple mechanisms: dysbiotic bacteria producing neuroactive compounds (propionic acid from Clostridia species is a proposed neurotoxin affecting mitochondrial function and GABA/glutamate balance), intestinal permeability allowing dietary opioid peptides (gliadomorphin from wheat, casomorphin from dairy) to reach the CNS.
GFCF (Gluten-Free, Casein-Free) diet: A subset of ASD children show measurable improvement with GFCF elimination — theoretically from reduced opioid peptide burden. Whiteley 2010 Nutritional Neuroscience and Whiteley 2012 meta-analysis demonstrated behavioral improvement in some ASD children, though rigorous double-blind evidence is limited. The functional medicine approach: trial GFCF elimination for 3-6 months in ASD children with GI symptoms, opioid peptide elevation (measured in urine), or elevated anti-gliadin/anti-casein antibodies.
Mitochondrial dysfunction in autism: Pathak 2011 and Frye 2012 documented mitochondrial dysfunction in approximately 5% of ASD children (frank mitochondrial disease) and metabolic evidence of mitochondrial dysfunction in up to 30-50% more. Mitochondrial support (CoQ10, B vitamins, carnitine, antioxidants) is a component of functional ASD protocols.
Folate receptor autoantibodies (FRAAs): Ramaekers 2005 and Frye 2012 documented elevated folate receptor autoantibodies in a significant proportion of ASD children — blocking cerebral folate transport and producing “cerebral folate deficiency syndrome.” This is treatable with high-dose leucovorin (folinic acid) — Frye 2013 demonstrated significant improvement in ASD symptoms with leucovorin in FRAA-positive children. Testing for FRAAs should be considered in ASD evaluation.
Childhood Obesity: The Functional Pediatrics Approach
Childhood obesity requires understanding beyond “eat less, move more” — the functional medicine approach identifies the specific biological drivers:
Ultra-processed food exposure and reward circuit dysregulation: Ultra-processed foods (UPF) — industrially manufactured products with extensive food additives — constitute 67% of American children’s caloric intake (Vandevijvere 2019). UPFs are engineered to maximize bliss point (the optimal combination of sugar, fat, and salt for dopaminergic reward activation), drive overconsumption, and disrupt satiety signaling via leptin resistance. UPF consumption is directly associated with increased child obesity risk in multiple prospective cohort studies (Llavero-Valero 2021 PREDIMED-Plus).
Endocrine disrupting chemicals and pediatric obesity: Phthalates, BPA, and PFAS directly promote adipogenesis (fat cell differentiation) via PPAR-γ activation — a process termed “obesogen” biology (Grün 2006). Children have higher EDC exposure per body weight than adults and reduced detoxification capacity. Swan 2005 documented prenatal phthalate exposure’s effects on male reproductive development; prenatal EDC exposure affects metabolic programming with measurable effects on childhood body fat distribution.
Sleep and childhood obesity: Insufficient sleep is a major, underappreciated driver of pediatric obesity. Nixon 2008 (Pediatrics, n=519) demonstrated each additional hour of sleep associated with 0.49 unit lower BMI z-score. The mechanism: sleep deprivation increases ghrelin (hunger hormone) and decreases leptin (satiety hormone), increases cortisol-driven visceral fat accumulation, and reduces physical activity through fatigue. American Academy of Pediatrics sleep recommendations: 9-12 hours for ages 6-12, 8-10 hours for teens.
Childhood Allergies and the Allergy Prevention Window
Food allergy prevalence in US children has increased from 3.4% in 1997 to 7.6% in 2016 (CDC NHIS data) — an increase that cannot be explained by genetics and reflects environmental microbiome disruptions. The LEAP trial (Du Toit 2015 NEJM) was paradigm-shifting: early introduction of peanut protein to high-risk infants (those with severe eczema or egg allergy) at 4-11 months REDUCED peanut allergy development by 81% compared to avoidance — the exact opposite of previous allergist recommendations. This drove USDA Dietary Guidelines 2020 to recommend allergenic food introduction early in infancy for all infants.
The hygiene hypothesis evolved: Strachan’s original 1989 hygiene hypothesis proposed that reduced childhood infection exposure increased allergy risk. The current “old friends” hypothesis (Rook 2013) more accurately describes the mechanism: reduced exposure to environmental microorganisms (soil bacteria, parasites, diverse microbial environments) fails to appropriately educate the regulatory T cell (Treg) arm of the immune system, leaving it unable to suppress allergic (Th2) responses. Functional interventions: early allergen introduction, probiotic supplementation in the first year of life (Abrahamsson 2007 JA&CI demonstrated Lactobacillus reuteri reduced eczema incidence in high-risk infants), vitamin D optimization during pregnancy and infancy, and diverse microbial exposure through outdoor play, pets, and farms.
Functional Pediatrics at The Private Practice
Dr. Biernacki’s functional pediatric evaluation provides what a 15-minute well-child visit cannot — a comprehensive assessment of the child’s nutritional status, microbiome health, environmental exposures, sleep, and developmental trajectory. For children with ADHD, autism, allergies, obesity, recurrent infections, or behavioral concerns, functional medicine identifies the specific biological contributors driving symptoms and implements targeted interventions that are both evidence-based and developmentally appropriate.
The pediatric evaluation includes: ferritin, omega-3 index, zinc, magnesium, vitamin D, comprehensive microbiome assessment (where appropriate), food sensitivity panel, and detailed dietary, sleep, and environmental exposure history. The goal is addressing modifiable root causes — not simply managing symptoms with medications that mask underlying deficiencies and dysregulation. To schedule a comprehensive pediatric functional medicine evaluation for your child, call (810) 206-1402 or visit theprivatepractice.co.
Frequently Asked Questions About Functional Pediatrics
Q: What is the functional medicine approach to recurrent ear infections in children?
A: Recurrent otitis media in children frequently has identifiable functional drivers: (1) Dairy sensitivity — dairy products increase mucus production in sensitive children, creating Eustachian tube congestion that impairs middle ear drainage. A 2-4 week dairy elimination trial often dramatically reduces otitis frequency. (2) Environmental allergies — assess for airborne allergens causing Eustachian tube dysfunction. (3) Gut microbiome disruption — antibiotic treatment of each episode further disrupts the microbiome, reducing immune resilience and increasing susceptibility to the next infection. Probiotic supplementation and dietary intervention may break this cycle. (4) Xylitol — Uhari 1998 BMJ RCT demonstrated xylitol chewing gum (5 pieces/day) reduced otitis media incidence by 40%; xylitol inhibits pneumococcal and Haemophilus influenzae adhesion to upper respiratory mucosa.
Q: Are there natural alternatives to stimulant medications for ADHD?
A: For mild-moderate ADHD, functional medicine interventions can be highly effective before or alongside medication: iron repletion to ferritin >40 ng/mL (if deficient), omega-3 supplementation (1-2g EPA+DHA/day), magnesium-B6 combination, artificial food color and sodium benzoate elimination, zinc supplementation, and sleep optimization. These interventions address the biological deficiencies driving ADHD symptoms and have substantially less side-effect burden than stimulants. For moderate-severe ADHD where quality of life is significantly impaired, stimulant medications remain an important tool — but functional medicine interventions improve treatment response and may reduce medication requirements over time.
Q: Can a child’s gut microbiome recover after multiple antibiotic courses?
A: Yes, with active support. Unlike adults, children have the advantage of microbiome developmental plasticity — the window for microbiome establishment (ages 0-3) allows recolonization if appropriate microbial exposure and dietary conditions are provided. Active restoration strategies: Saccharomyces boulardii during and after antibiotic courses, multi-strain probiotic supplementation (Lactobacillus rhamnosus GG and Bifidobacterium strains specifically), prebiotic fiber (resistant starch in age-appropriate foods), dietary diversity (30+ plant varieties per week), fermented foods introduction (yogurt, kefir in older children), and reducing re-exposure to antibiotic-disrupting agents (chlorinated tap water kills gut bacteria — filtered water is recommended).
Q: When should I consider functional pediatric evaluation for my child?
A: Functional pediatric evaluation is particularly valuable for children with: (1) Chronic GI symptoms (recurrent abdominal pain, constipation, diarrhea, IBS-like symptoms). (2) ADHD, learning difficulties, or behavioral concerns — especially if medication hasn’t fully resolved symptoms or has significant side effects. (3) Recurrent infections (ear infections, strep, respiratory infections) suggesting immune dysfunction. (4) Food allergies, eczema, or asthma. (5) Developmental concerns or autism spectrum features. (6) Unexplained fatigue, headaches, or growth concerns. (7) Parents who want to optimize their child’s health proactively, regardless of whether there is a defined diagnosis — nutritional optimization, microbiome health, and toxin reduction are beneficial for all children.